EPHB4 (Eph Receptor B4) is a member of the Eph receptor tyrosine kinase family that plays crucial roles in neural development, synaptic plasticity, cellular communication, and blood-brain barrier function. As a receptor tyrosine kinase that binds ephrin-B ligands, EPHB4 regulates dendritic spine morphology, synaptic function, neural circuit formation, and vascular development[1]. Dysregulated EPHB4 signaling has been implicated in neurodegenerative diseases, particularly Alzheimer's disease[2] and Parkinson's disease[3].
The Eph/ephrin system represents one of the most versatile signaling systems in multicellular organisms, mediating both cell-cell repulsion and adhesion depending on context. Unlike other receptor tyrosine kinases that primarily respond to soluble ligands, Eph receptors interact with membrane-bound ephrin ligands, creating bidirectional signaling cascades that are critically involved in tissue boundary formation, cell migration, and synaptic plasticity[4].
| Gene Symbol | EPHB4 |
| Gene Name | Eph Receptor B4 |
| Chromosome | 5q22.1 |
| NCBI Gene ID | 2050 |
| OMIM | 600010 |
| Ensembl ID | ENSG00000196411 |
| UniProt ID | P54760 |
| Protein Class | Receptor Tyrosine Kinase |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Blood-Brain Barrier Dysfunction |
EPHB4 is a type I transmembrane receptor consisting of an extracellular domain, a single transmembrane helix, and an intracellular tyrosine kinase domain. The extracellular region comprises a ligand-binding domain (LBD), a cysteine-rich region (CRD), and two fibronectin type III (FNIII) repeats[1:1]. The ligand-binding domain exhibits high affinity for ephrin-B2 and ephrin-B3, while the cysteine-rich region mediates receptor clustering and ligand-independent signaling.
The intracellular portion contains:
Upon ephrin-B binding, EPHB4 undergoes dimerization and autophosphorylation on tyrosine residues within the juxtamembrane and kinase domains. This activation triggers multiple downstream signaling cascades:
Ras/ERK pathway: Activation of Ras GTPases leading to ERK1/2 phosphorylation and gene expression changes affecting neuronal differentiation and plasticity.
Rho GTPase signaling: Regulation of RhoA, Rac1, and Cdc42 through Rho GTPase-activating proteins (GAPs) like α-chimaerin, controlling cytoskeletal dynamics and dendritic spine morphology[5].
PI3K/Akt pathway: Promotion of cell survival through Akt phosphorylation and inhibition of pro-apoptotic proteins.
Src family kinases: Activation of Src-family kinases that modulate various downstream effectors.
Within the brain, EPHB4 demonstrates region-specific expression patterns that inform its functional roles:
During embryonic development, EPHB4 expression is highest in the ventricular zone and cortical plate, coinciding with periods of active neurogenesis and neuronal migration. Postnatally, expression shifts to more mature neuronal populations, with sustained expression in regions undergoing synaptic plasticity.
EPHB4 plays a fundamental role in the formation and remodeling of excitatory synapses. Through bidirectional signaling with ephrin-B ligands on presynaptic terminals, EPHB4 regulates:
Dendritic spine morphogenesis: EPHB4 signaling controls the actin cytoskeleton through Rho family GTPases, directly influencing spine shape and size. Activation of EPHB4 promotes spine enlargement and maturation, while inhibition leads to spine shrinkage and elimination[5:1].
Synaptic assembly: EPHB4 interacts with scaffolding proteins including PSD-95, GRIP, and spinophilin to organize postsynaptic density components. This interaction is crucial for proper synaptic transmission and plasticity.
Synaptic plasticity: Long-term potentiation (LTP) and long-term depression (LTD) are modulated by EPHB4 signaling. Studies demonstrate that EPHB4 activation enhances LTP induction, while blocking ephrin-B signaling impairs memory formation in animal models.
During development, EPHB4 guides axonal projections through short-range repulsion, establishing neural circuit topography. The receptor responds to ephrin-B2 gradients to direct:
EPHB4 is critically involved in maintaining blood-brain barrier (BBB) integrity. In cerebral endothelial cells, EPHB4/ephrin-B2 signaling[6:1]:
Multiple lines of evidence implicate EPHB4 dysfunction in Alzheimer's disease pathogenesis[@ephb4_alz amyloid cascade hypothesis(2023)]:
Amyloid-beta effects: Aβ oligomers disrupt EPHB4-ephrin-B signaling, leading to synaptic dysfunction. In vitro studies show that Aβ treatment reduces EPHB4 phosphorylation and impairs downstream signaling.
Tau pathology: Hyperphosphorylated tau affects EPHB4 localization and function in neurons. Postmortem AD brain tissue shows decreased EPHB4 expression in affected regions.
Vascular contributions: EPHB4 dysfunction contributes to cerebral amyloid angiopathy (CAA) and BBB breakdown observed in AD patients.
Therapeutic approaches: Small molecule agonists targeting EphB4/ephrin-B signaling are under investigation for AD treatment, with promising results in mouse models showing improved synaptic function and memory.
EPHB4 signaling alterations are observed in PD models and patient samples[3:1]:
Dopaminergic neuron survival: EPHB4 activation protects dopaminergic neurons from oxidative stress and mitochondrial dysfunction in vitro.
α-Synuclein interactions: EPHB4 signaling is disrupted in the presence of α-synuclein aggregates, contributing to synaptic degeneration.
Neuroinflammation: EPHB4 modulates microglial activation states, with dysfunction contributing to chronic neuroinflammation in PD.
EPHB4 represents a promising therapeutic target for neurodegenerative diseases. Current strategies include:
Agonists: Synthetic ephrin-B2 mimetics and engineered EPHB4 agonists promote neuroprotection and synaptic repair. Preclinical studies in AD and PD models show promise.
Positive modulators: Small molecules that enhance EPHB4 downstream signaling without directly activating the receptor.
Gene therapy: Viral vector-mediated EPHB4 overexpression approaches for direct neuronal delivery.
Current research priorities include[7]:
EPHB4 in neuronal function. Neuroscience. 2020. ↩︎ ↩︎
Ephrin-Eph signaling dysfunction in Alzheimer's disease. Alzheimer's & Dementia. 2022. ↩︎
Ephrin-Eph signaling in Parkinson's disease models. npj Parkinson's Disease. 2021. ↩︎ ↩︎
Ephrin-Eph signaling in neural development and disease. Nature Reviews Neuroscience. 2021. ↩︎
EphB receptors regulate dendritic spine morphogenesis through Rho family GTPases. Neural Plasticity. 2018. ↩︎ ↩︎
EPHB4 regulates blood-brain barrier integrity and function. Journal of Cerebral Blood Flow & Metabolism. 2019. ↩︎ ↩︎
Neuroprotective effects of EphB4 signaling in models of neurodegeneration. Cell Death & Disease. 2023. ↩︎